These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2469865)

  • 1. Nitrendipine inhibition of calcium current in rat vascular muscle cells.
    Hermsmeyer K; Sturek M; Rusch NJ
    J Cardiovasc Pharmacol; 1988; 12 Suppl 5():S100-3. PubMed ID: 2469865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological modulation of calcium and potassium channels in isolated vascular smooth muscle cells.
    Klöckner U; Trieschmann U; Isenberg G
    Arzneimittelforschung; 1989 Jan; 39(1A):120-6. PubMed ID: 2541731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydropyridine binding and calcium channel function in clonal rat adrenal medullary tumor cells.
    Kunze DL; Hamilton SL; Hawkes MJ; Brown AM
    Mol Pharmacol; 1987 Apr; 31(4):401-9. PubMed ID: 2437436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium antagonists and excitation of the vascular muscle membrane.
    Hermsmeyer K; Kuthe C
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S933-6. PubMed ID: 6085380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).
    Bezprozvanny I; Tsien RW
    Mol Pharmacol; 1995 Sep; 48(3):540-9. PubMed ID: 7565636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine kinases modulate the activity of single L-type calcium channels in vascular smooth muscle cells from rat portal vein.
    Liu H; Sperelakis N
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1063-8. PubMed ID: 9365814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of nitrovasodilators and cyclic GMP on ET-1-activated Ca(2+)-permeable nonselective cation channel in rat aortic smooth muscle cells.
    Minowa T; Miwa S; Kobayashi S; Enoki T; Zhang XF; Komuro T; Iwamuro Y; Masaki T
    Br J Pharmacol; 1997 Apr; 120(8):1536-44. PubMed ID: 9113376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The voltage-dependent non-selective cation channel sensitive to the L-type calcium channel blocker efonidipine regulates Ca2+ influx in brain vascular smooth muscle cells.
    Matsuoka T; Nishizaki T; Nomura T
    Biochem Biophys Res Commun; 1997 Nov; 240(2):484-7. PubMed ID: 9388505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of voltage-gated L-type calcium channels by labedipinedilol-A involves protein kinase C in rat cerebrovascular smooth muscle cells.
    Wu BN; Chen ML; Dai ZK; Lin YL; Yeh JL; Wu JR; Chen IJ
    Vascul Pharmacol; 2009; 51(2-3):65-71. PubMed ID: 19298869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological and radioligand binding studies of elgodipine and derivatives in portal vein myocytes.
    Lepretre N; Arnaudeau S; Mironneau J; Rakotoarisoa L; Mironneau C; Galiano A
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1209-15. PubMed ID: 7996428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voltage- and use-dependent inhibition of Na+ channels in rat sensory neurones by 4030W92, a new antihyperalgesic agent.
    Trezise DJ; John VH; Xie XM
    Br J Pharmacol; 1998 Jul; 124(5):953-63. PubMed ID: 9692781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding.
    Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H
    Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular muscle calcium channel modulation in hypertension.
    Hermsmeyer K; Sturek M; Marvin W; Mason R; Puga A
    J Cardiovasc Pharmacol; 1989; 14 Suppl 6():S45-8. PubMed ID: 2478824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tetrandrine on free intracellular calcium in cultured calf basilar artery smooth muscle cells.
    Wang B; Xiao JG
    Acta Pharmacol Sin; 2002 Dec; 23(12):1121-6. PubMed ID: 12466050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of L-type Ca2+ channels in clonal rat pituitary cells by membrane depolarization.
    Liu J; Bangalore R; Rutledge A; Triggle DJ
    Mol Pharmacol; 1994 Jun; 45(6):1198-206. PubMed ID: 8022413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition of voltage-gated K+ current in rat intrapulmonary arterial smooth muscle cells by endothelin-1].
    Fan ZW; Zhang ZX; Xu YJ
    Yao Xue Xue Bao; 2004 Jan; 39(1):9-12. PubMed ID: 15127573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen (estrogen antagonist) inhibits voltage-gated calcium current and contractility in vascular smooth muscle from rats.
    Song J; Standley PR; Zhang F; Joshi D; Gappy S; Sowers JR; Ram JL
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1444-53. PubMed ID: 8667209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dihydropyridine nitrendipine reduces N-methyl-D-aspartate (NMDA)-evoked currents of rodent cortical neurons through a direct interaction with the NMDA receptor-associated ion channel.
    Skeen GA; White HS; Twyman RE
    J Pharmacol Exp Ther; 1994 Oct; 271(1):30-8. PubMed ID: 7965728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of myricetin stimulation of vascular L-type Ca2+ current.
    Fusi F; Sgaragli G; Saponara S
    J Pharmacol Exp Ther; 2005 May; 313(2):790-7. PubMed ID: 15665142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.